Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tricarbonyl[tris(1-methyl-1H-imidazol-2-yl-?N(3))methanol]manganese(I) trifluoromethanesulfonate.

ABSTRACT: In the title compound, [Mn(C(13)H(16)N(6)O)(CO)(3)](CF(3)O(3)S), the Mn(I) atom has a slightly distorted octa-hedral geometry. The three CO ligands have C-Mn-C angles in the range 89.44?(10)-92.31?(9)°, while the three N atoms of the tripodal ligand form significantly smaller N-Mn-N angles of 82.76?(2)-85.51?(6)°. The three N atoms of the tripodal ligand and the three carbonyl ligands coordinate facially. In the crystal, the trifluoro-methane-sulfonate counter anion is connected by a medium-strength O-H?O hydrogen bond to the hydroxyl group of the manganese complex.

SUBMITTER: Reiss GJ

PROVIDER: S-EPMC3435617 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Tricarbonyl[tris(1-methyl-1H-imidazol-2-yl-κN(3))methanol]manganese(I) trifluoromethanesulfonate.

Reiss Guido J GJ Kunz Peter C PC

Acta crystallographica. Section E, Structure reports online 20120823 Pt 9

In the title compound, [Mn(C(13)H(16)N(6)O)(CO)(3)](CF(3)O(3)S), the Mn(I) atom has a slightly distorted octa-hedral geometry. The three CO ligands have C-Mn-C angles in the range 89.44 (10)-92.31 (9)°, while the three N atoms of the tripodal ligand form significantly smaller N-Mn-N angles of 82.76 (2)-85.51 (6)°. The three N atoms of the tripodal ligand and the three carbonyl ligands coordinate facially. In the crystal, the trifluoro-methane-sulfonate counter anion is connected by a medium-stre ...[more]

PMID: 22969490

Similar Datasets

Diazido-bis[(1-methyl-1H-benzimidazol-2-yl)methanol-κN,O]manganese(II).

Project description:The title complex, [Mn(N(3))(2)(C(9)H(10)N(2)O)(2)], possesses crystallographically imposed twofold symmetry. The Mn(II) atom is coordinated by four N atoms and two O atoms in a distorted octa-hedral geometry. The crystal packing is stabilized by strong inter-molecular O-H⋯N hydrogen bonds.

| S-EPMC2979954 | biostudies-literature

(1H-Imidazol-4-yl)methanol.

Project description:The title compound, C4H6N2O, displays two predominant hydrogen-bonding inter-actions in the crystal structure. The first is between the unprotonated imidazole N atom of one mol-ecule and the hy-droxy H atom of an adjacent mol-ecule. The second is between the hy-droxy O atom of one mol-ecule and the imidazole N-H group of a corresponding mol-ecule. These inter-actions lead to the formation of a two-dimnensional network parallel to (10-1). C-H?O inter-actions also occur.

| S-EPMC3770414 | biostudies-other

Bis[?-4-(1H-imidazol-3-ium-1-yl)benzoato-?O:O']bis-[(methanol)tris-(nitrato-?O,O')terbium(III)].

Project description:In the centrosymmetric dinuclear title complex, [Tb(2)(NO(3))(6)(C(10)H(8)N(2)O(2))(2)(CH(3)OH)(2)], the Tb atoms are bridged by the carboxyl-ate groups of the two 4-(1H-imidazol-3-ium-1-yl)benzoate (iba) ligands. The iba ligand adopts a zwitterionic form with a protonated imidazole group. The Tb atom adopts a distorted tricapped trigonal-prismatic coordination geometry and is coordinated by six O atoms of three chelating nitrate ions, one O atom of the methanol mol-ecule and two O atoms of two iba ligands. The intra-molecular Tb?Tb separation is 5.1419?(3)?Å. O-H?O and N-H?O hydrogen bonds connect complex mol-ecules into a two-dimensional network.

| S-EPMC3051581 | biostudies-literature

5,5'-Bis[(1H-imidazol-1-yl)meth-yl]-2,2'-bipyridine methanol disolvate.

Project description:The title compound, C(18)H(16)N(6)·2CH(3)OH, was prepared by the reaction of 5,5'-bis-(bromo-meth-yl)-2,2'-bipyridine with imidazole. The main mol-ecule lies on an inversion center located at the mid-point of the C-C bond joining the two pyridine rings. The asymmetric unit therefore contains one half-mol-ecule and one methanol solvent mol-ecule. The dihedral angle between the pyridine and imidazole rings is 72.32 (5)°. In the crystal, weak inter-molecular O-H⋯N, C-H⋯N and C-H⋯O hydrogen bonds contribute to the stabilization of the packing.

| S-EPMC3051999 | biostudies-literature

(Salicylato)[tris-(1-methyl-1H-benz-imidazol-2-ylmeth-yl)amine]copper(II) perchlorate dimethyl-formamide disolvate.

Project description:In the title complex, [Cu(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·2C(3)H(7)NO, the Cu(II) ion is five-coordinated by four N atoms from the tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine ligand and an O atom of the monodentate salicylate ligand. The N(4)O donor set defines a coordination geometry inter-mediate between square-pyramidal and trigonal-bipyramidal. The crystal structure is stabilized by O-H⋯O inter-actions. The atoms of the aromatic ring of the salicylate ligand are disordered over two sites of equal occupancy. In addition, one of the dimethyl-formamide solvent mol-ecules is partially disordered over two positions, of approximately equal occupancy.

| S-EPMC2914911 | biostudies-literature

Methyl 2-(2-methyl-4-nitro-1H-imidazol-1-yl)acetate.

Project description:In the crystal of the title compound, C7H9N3O4, mol-ecules are linked by weak C-H⋯O hydrogen bonds into chains along the a-axis direction. The dihedral angle between the ring and the nitro group is 3.03 (6), while that between the ring and the acetate group is 85.01 (3)°.

| S-EPMC3684924 | biostudies-literature

1-(2-Methyl-5-nitro-1H-imidazol-1-yl)acetone.

Project description:In the mol-ecule of the title compound, C7H9N3O3, the nitro and carbonyl groups are tilted with respect to the imidazole ring by 9.16?(6) and 65.47?(7)°, respectively. Neighbouring chains are linked via C-H?N and C-H?O hydrogen bonds forming two-dimensional slab-like networks lying parallel to (01-1).

| S-EPMC3629604 | biostudies-literature

Bis[tris-(1H-pyrazol-1-yl-?N)methane]-nickel(II) bis-{[tris-(1H-pyrazol-1-yl-?N)methane]-tris-(thio-cyanato-?N)nickelate(II)} methanol disolvate.

Project description:Attempts to prepare the mononuclear [(tpm)Ni(II)L(3)](-1) [tpm = tris-(1H-pyrazol-1-yl)methane and L = thio-cyanate] anion yielded the methanol-solvated salt, [(tpm)(2)Ni(II)][(tpm)Ni(II)(NCS)(3)](2)·2CH(3)OH or [Ni(C(10)H(10)N(6))(2)][Ni(NCS)(3)(C(10)H(10)N(6))](2)·2CH(3)OH. The asymmetric unit consists of half a centrosymmetric bis-[tris-(1H-pyrazol-1-yl)methane]-nickel(II) cation and an octa-hedral nickelate(II) anion bound to one tpm and three L ligands, and a methanol solvent mol-ecule. One of the L ligands is disordered over two positions with occupancy factors of 0.650?(3) and 0.350?(3). There are O-H?S inter-actions between the methanol and the disordered thio-cyanate anion, and a weak C-H?O hydrogen bond between the cation and the methanol O atom.

| S-EPMC3238592 | biostudies-literature

Tris[2-(1H-imidazol-2-yl)imidazol-1-ido]cobalt(III).

Project description:In the title compound, [Co(C(6)H(5)N(4))(3)], the Co(III) atom adopts a distorted octa-hedral CoN(6) coordination geometry, arising from three N,N'-bidentate deprotonated 2,2'-biimidazole ligands. The dihedral angles between the five-membered rings of the ligands are 4.1?(2), 9.4?(2) and 10.5?(2)°. In the crystal, mol-ecules are linked by N-H?N hydrogen bonds, generating a layered network lying in (11).

| S-EPMC2979296 | biostudies-other

Acrylato[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]cobalt(II) perchlorate-dimethyl-formamide-methanol (2/2/3).

Project description:In the title complex, [Co(C(3)H(3)O(2))(C(27)H(27)N(7))]ClO(4)·C(3)H(7)NO·1.5CH(4)O, the Co(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine (mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.90 and 0.10. In addition, the solvent hemimethanol mol-ecule is disordered over two positions with equal occupancies. The crystal structure is stabilized by weak intermolecular O-H?O hydrogen bonds.

| S-EPMC2959638 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data